DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft Confirms Receipt of Proposal to Submit Takeover Bid
|
DGAP-News: RHÖN-KLINIKUM AG
/ Key word(s): Offer/Miscellaneous
RHÖN-KLINIKUM Aktiengesellschaft Confirms Receipt of Proposal to Submit Takeover Bid
02.03.2020 / 08:54
The issuer is solely responsible for the content of this announcement.
Corporate News
Bad Neustadt / Saale | 2nd March 2020
RHÖN-KLINIKUM Aktiengesellschaft Confirms Receipt of Proposal to Submit Takeover Bid
Asklepios Kliniken GmbH & Co. KGaA informed the Company last Friday that it intends to offer the shareholders of RHÖN-KLINIKUM Aktiengesellschaft a voluntary public takeover bid for all outstanding shares of the Company in return for payment of a sum in the amount of Euro 18.00 per share. The Board of Management of RHÖN-KLINIKUM Aktiengesellschaft was hitherto not involved. As soon as the Company receives the bidding documentation from Asklepios Kliniken GmbH & Co. KGaA, the Board of Management and Supervisory Board will thoroughly review such documentation and then issue their detailed comments pursuant to § 27, German Securities Acquisition and Takeover Act (Wertpapiererwerbs- und Übernahmegesetz - WpÜG).
-----------------------------------------------------
RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. The hospital group offers excellent medical care with a direct link to universities and research institutes. More than 860,000 patients are treated every year at the five group hospitals located in Bad Berka, Bad Neustadt, Frankfurt (Oder), Giessen and Marburg where more than 17,000 employees work. We have now put our ideal RHÖN healthcare campus concept into practice at our site in Bad Neustadt. It provides fully comprehensive forward-looking healthcare, thus crossing sectoral boundaries. The patient-orientated concept takes account of the increasing importance of out-patient medical services and raises modern healthcare in rural areas to a new level of excellence.
More information under www.rhoen-klinikum-ag.com
Follow us
www.twitter.com/rhoenklinikumag
www.xing.com/companies/rhön-klinikumag
www.youtube.com/rhönklinikumag
Contact
RHÖN-KLINIKUM AG | Head of Corporate Communications and Marketing
Elke Pfeifer
Telephone: +49 9771 65-12110 | E-Mail: [email protected]
RHÖN-KLINIKUM AG | Head of Investor Relations and Treasury
Julian Schmitt
Telephone: +49 9771 65-12250 | E-Mail: [email protected]
RHÖN-KLINIKUM AG | Schlossplatz 1 | 97616 Bad Neustadt / Saale, Germany
02.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
| Language: |
English |
| Company: |
RHÖN-KLINIKUM AG |
|
Salzburger Leite 1 |
|
97616 Bad Neustadt a.d.Saale |
|
Germany |
| Phone: |
+49 (0)9771 - 65-0 |
| Fax: |
+49 (0)9771 - 97 467 |
| E-mail: |
[email protected] |
| Internet: |
www.rhoen-klinikum-ag.com |
| ISIN: |
DE0007042301 |
| WKN: |
704230 |
| Indices: |
SDAX |
| Listed: |
Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange |
| EQS News ID: |
987009 |
| |
| End of News |
DGAP News Service |
987009 02.03.2020
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
1.211,08 |
1.232,91 |
1.303,90 |
1.360,16 |
1.402,01 |
1.446,09 |
1.463,98 |
| EBITDA1,2 |
97,82 |
125,54 |
125,33 |
80,23 |
101,16 |
105,65 |
105,88 |
| EBITDA-Marge3 |
8,08 |
10,18 |
9,61 |
5,90 |
7,22 |
7,31 |
|
| EBIT1,4 |
38,70 |
64,94 |
56,80 |
10,60 |
30,52 |
36,11 |
40,40 |
| EBIT-Marge5 |
3,20 |
5,27 |
4,36 |
0,78 |
2,18 |
2,50 |
2,76 |
| Jahresüberschuss1 |
36,74 |
51,19 |
44,48 |
2,46 |
30,23 |
26,94 |
40,17 |
| Netto-Marge6 |
3,03 |
4,15 |
3,41 |
0,18 |
2,16 |
1,86 |
2,74 |
| Cashflow1,7 |
80,30 |
49,50 |
47,30 |
113,30 |
97,50 |
41,30 |
109,00 |
| Ergebnis je Aktie8 |
0,53 |
0,73 |
0,65 |
0,02 |
0,42 |
0,38 |
0,58 |
| Dividende8 |
0,22 |
0,29 |
0,00 |
0,00 |
0,00 |
0,15 |
0,35 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: KPMG
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Rhön-Klinikum |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| 704230 |
10,800 |
Halten |
723,19 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 18,00 |
27,98 |
0,66 |
18,46 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 0,58 |
6,63 |
0,49 |
6,24 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 0,15 |
0,00 |
0,00 |
05.06.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 08.05.2024 |
08.08.2024 |
07.11.2024 |
28.03.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 0,11% |
-3,79% |
8,00% |
-16,92% |
|
|
RHÖN-KLINIKUM AG DE0007042301